Allergan to Sell Facility in Italy
- Share via
IRVINE — Allergan Inc. said Thursday it has agreed to sell its ophthalmic pharmaceutical manufacturing facility in Pomezia, Italy, to a management team there.
Allergan will also sell certain ophthalmic pharmaceutical products to the management team led by Emidio Fedeli, currently operations director of Allergan S.p.A.
The sale is part an effort by Allergan to streamline operations. After the sale, the new company will be called Tubilux Pharma S.p.A. and will continue to manufacture ophthalmic pharmaceutical products for Allergan under a supply agreement, as well as market its own range of ophthalmic pharmaceutical products.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
